Dr. Lenkinski is a Professor of Radiology at Harvard Medical School and a Vice-Chairman and Director of Radiology Research at Beth Israel Deaconess Medical Center. One of his major research interests is the clinical applications of in vivo Magnetic Resonance spectroscopy. Dr Lenkinski is also developing in vivo multinuclear MR imaging methods. A more recent area of interest has been molecular imaging. He received his Ph.D in Chemistry from the University of Houston. He has authored many articles in peer - reviewed journals and was awarded several patents.
Allan G. Johnson, Ph.D., Scientific Advisor
Dr. Johnson is Director of the Center for In Vivo Microscopy, an NIH/NCRR National Biomedical Technology Resource Center. He received his PhD in Physics from Duke University in 1974 in electron spin resonance under Professor Walter Gordy. He was responsible for installing the first CT system at Duke in 1974 (the 2nd CT system in the US). From 1981-83 he worked with GE to install the world’s first high field (1.5T) clinical MRI system. He holds appointments in Radiology, Physics, and Biomedical Engineering as the Charles E. Putman University Professor. He is co-author on more than 250 peer-reviewed papers. Dr. Johnson is the principal investigator of the Duke Molecular Imaging Center supported by the National Cancer Institute to develop new imaging strategies for the detection and characterization of cancer and the application of those techniques in preclinical studies. He is also a principal investigator in the Mouse Biomedical Informatics Research Network (MBIRN), a multi-institutional collaboration that integrates studies in the mouse from millimeter to submicron resolution. Dr. Johnson’s personal research is in magnetic resonance histology (MRH), the application of MR microscopy to the study of tissue architecture. The use of MRH for morphologic phenotyping in the mouse was first suggested by Dr. Johnson and his colleagues in 1993. More recently MRH has been extended to 21 microns in the mouse brain for high throughput phenotyping. Dr. Johnson and his team are currently focused on extending the technology to achieve spatial resolution approaching the theoretical limit of ~10 microns.
Peter Bendel, Ph.D., Scientific Advisor
Dr. Peter Bendel is a Senior Staff Researcher at the Weizmann Institute of Science, where he supervises the NMR and MRI facilities in the Department of Chemical Research Support. He has over 30 years’ of experience in the field of MRI, including having worked as R & D Physicist at Elscint, as a Visiting Scientist at the University of Tennessee Medical Center, and in the Corporate Research Laboratory of ExxonMobil.
Gil Navon, Ph.D., Scientific Advisor
Dr. Navon is an Active Professor Emeritus of Chemistry at Tel Aviv University. He has contributed to the field of biomedical NMR from itsbeginning. He has achieved many original breakthroughs including the first 31P NMR of live cancer and bacterial cells, multiple quantum NMR of 23Na in perfused rat hearts and cartilage, MRI of electrical currents, parallel MRI with coil arrays, indirect detection of H217O, SPINOE and DQF NMR and MRI of connective tissues and nerves. He is co-author on more than 250 peer-reviewed papers and was awarded 12 patents.
